Spinal Cord Stimulation (SCS): Relief tailored for your pain
Boston Scientific’s proven SCS therapy can be personalized to deliver the lasting relief you need — where and when you need it.
Our Spinal Cord Stimulation (SCS) is:
• Clinically proven to provide long-term relief from chronic pain
How does SCS work?
You feel pain when nerves send pain signals through your spinal cord to your brain.
Your spinal cord stimulator (SCS) system is designed to interrupt these signals so you don’t perceive them as pain.
A small device called a spinal cord stimulator is implanted under the skin.
Thin, flexible “leads” are connected to the spinal cord stimulator and placed near specific nerves in the back.
The spinal cord stimulator sends mild pulses through the leads to the nerves.
The pulses interrupt the pain signals on the way to the brain.
See how SCS works
Watch our animated SCS guide.
Who should get a Spinal Cord Stimulator?
Spinal cord stimulation (SCS) therapy is used to treat different kinds of chronic pain – pain lasting six months or more. This can include pain in the back, legs, and feet, or a combination of different pain areas. Boston Scientific’s SCS systems are indicated for people with conditions causing pain, including failed back surgery syndrome (FBSS), Complex Regional Pain Syndrome (CRPS), radicular pain syndrome, and more. (See complete indications and contraindications here.) A pain management specialist can tell you if SCS therapy may be right for you.
Spinal Cord Stimulator (SCS) System
The right therapy, right where you need it
Winner Best Overall Medical Device Solution
Choose tingling or non-tingling stimulation, or a combination of both.
Multiple therapy options for personalized relief
There are different kinds of SCS therapies.
Some therapies replace your pain with a tingling sensation. Others use a type of stimulation you don't feel at all.
With the WaveWriter Alpha SCS System, you can choose the therapy that works best for you — or use both at the same time.
The ability to deliver multiple therapies simultaneously* is unique to Boston Scientific SCS Systems and has been clinically proven to provide greater relief from chronic pain.1
Rapid and profound relief with FAST therapy
The WaveWriter Alpha SCS System features Boston Scientific’s unique, non-tingling FAST™ therapy. While other SCS systems use therapies that can take days to “wash in”, FAST is designed to provide immediate relief. In a recent clinical study, patients using FAST went from an average pain score of 6.5 to an average of 1.3 in a matter of minutes.2
And, because FAST uses less energy than other forms of non-tingling therapy, it may help to reduce the amount of charging you have to do or to extend the life of a non-rechargeable system.3
Watch real patients describe going from pain to relief in minutes.
Get back to everyday activities
Effectively managing your pain can help you get back to enjoying many of the little things in life you’ve missed. In a clinical study, patients using the Boston Scientific SCS therapy offered in the WaveWriter Alpha SCS System reported a greater improvement in their ability to do everyday activities† than patients reported in other studies using non-Boston Scientific SCS systems.4,5,6
The WaveWriter Alpha SCS System’s non-tingling therapy options can be used while driving or sleeping.
The right option now, and for the future
FULL BODY MRI:
The WaveWriter Alpha SCS System allows for conditional full body MRI scans.
Spinal cord stimulators are powered by batteries that are either rechargeable or non-rechargeable. Your doctor will help you choose which one is best for you. The WaveWriter Alpha SCS System offers both chargeable and non-rechargeable stimulators, so you can choose the right battery for you without compromising your therapy options.
Try your relief first
Before committing to SCS, find out if it will work for you by taking it for a “test drive” with a temporary trial system.
Real success stories
Talk to a real patient living with SCS therapy
Connect with real people living with pain and hear about their experience finding lasting relief by using a Boston Scientific solution.
Top 5 questions about SCS
Hear answers to the questions we get asked most often about SCS.
Learn about SCS with the mySCS™ app
Designed to help patients during their SCS trial, this free app also includes informative articles and resources on SCS for wherever you are on your journey.
Wondering if SCS may be right for you?
Take this quick quiz and find out. ⟶
*Paresthesia-free stimulation has been shown to be safe and effective in patients who have been treated successfully with paresthesia-inducing stimulation for at least 6 months.
†As measured by the Oswestry Disability Index at 3 months post implant.
References: 1. North, James, MD. WHISPER: A Multicenter, Prospective Randomized Controlled Trial Evaluating Subperception SCS at ≤ 1.2 kHz. Presentation at North American Neuromodulation Society (NANS), Las Vegas, NV, January 11-14, 2018. (N=70) 2. Clark S. Metzger, M. Blake Hammond, Jose F. Paz-Solis, William J. Newton, Simon J. Thomson, Yu Pei, Roshini Jain, Michael Moffitt, Luca Annecchino & Que Doan (2021) A novel fast-acting sub-perception spinal cord stimulation therapy enables rapid onset of analgesia in patients with chronic pain, Expert Review of Medical Devices, DOI: 10.1080/17434440.2021.1890580. (N=41) 3. FAST MOA computational modeling by Dr. Warren Grill’s lab at Duke University. Gilbert et al., Computational modeling predicts dorsal columns are involved in fast-acting sub-perception spinal cord stimulation (SCS). SFN 2021. 4. Wallace M. et al. Outcomes of a Prospective Randomized Controlled Trial Utilizing a Spinal Cord System Capable of Multiple Neurostimulation Modalities (COMBO). NANS Annual Meeting. January 2020 (N=89) 5. Kapural, Cong Yu, et al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology 2015; 123:851 -860 6. Deer, Timothy, et al. Success Using Neuromodulation With BURST (SUNBURST) Study: Results From a Prospective, Randomized Controlled Trial Using a Novel Burst Waveform. Neuromodulation: Technology at the Neural Interface. 21. 10.1111/ner.12698 7. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.